An antigen-based lateral flow assay for rapid screening of JEV and method thereof

overview

Japanese Encephalitis Virus (JEV) is a mosquito-borne infection and a leading cause of viral encephalitis in Asia. To enable rapid and early detection, an antigen-based Lateral Flow Assay (LFA) has been developed, offering faster and more sensitive screening for JEV compared to existing commercial kits, aiding in timely diagnosis and intervention.

Photo Gallery

6
TRL
0
Number of units currently deployed
7
No. of days or hours of training required

Key Features

Rapid –Provides quick results for timely screening.
Sensitive –Detects low levels of JEV antigen with high accuracy.
Supported –Technology can be transferred for commercialisation and deployment.